Monoclonal gammopathies with a high MC elicit altered phenotypic and genotypic features.
Greco
C
C
Dipt. Patalogia Clinica, Istituto Nazionale dei Tumori, Roma, Italy.
Alvino
S
S
Mosiello
A
A
Avilii
G
G
Mattei
F
F
Francavilla
V
V
Valente
F
F
Del Monte
G
G
Cianciulli
A M
AM
Gandolfo
G M
GM
D015703:Antigens, CD / Q000032:analysis; D005838:Genotype; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000097:blood; D007146:Immunoglobulin lambda-Chains / Q000097:blood; D016130:Immunophenotyping; D015850:Interleukin-6 / Q000097:blood; D009154:Mutation; D010265:Paraproteinemias / Q000097:blood / Q000175:diagnosis / Q000473:pathology*; D010641:Phenotype; D011379:Prognosis; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000097:blood / Q000235:genetics; D001613:beta 2-Microglobulin / Q000032:analysis
D015703:Antigens, CD; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains; D015850:Interleukin-6; D016271:Proto-Oncogene Proteins c-myc; D016159:Tumor Suppressor Protein p53; D001613:beta 2-Microglobulin